We propose a method of identifying a subset of the GLAS data which can justifiably be treated as a simple random sample in model-based biomass estimation.
However, this only happened in less than 3% of the sample in Models 3 and 4 when the Tobit method was used.> -wrap-foot> AbbreviationSD standardardeviationon, Min minimum, P10 10th percentile, Q1 1st quartile, Q3 third quartile, P90 90th percentile, Max maximum.
Although high-throughput RNA sequencing has recently become popular as an alternative to microarray analysis, the microarray platform, with its robust sample process and data analysis pipelines, is still the preferred choice for transcriptomic profiling involving a large number of samples in model plants with well-annotated genomes [ 14, 15].
Using changes in tDR expression between pre- and post-treatment samples in model fitting would explain less variation in the data (R = 40%%); however, since pre-treatment tRNA expression is a more clinically useful analysis, the better prediction value is fortuitous.
However, this was not the case for model 2 (see below), suggesting the null effects were attributable to the reduced sample size in model 1 (n = 62) because of non-compliance with accelerometer wear-time criteria.
Furthermore, the width of the CI indicated appreciable sample variability in model discrimination performance.
Each sample has a score along each model component which shows the location of the sample in this model and can be used to detect sample patterns, groupings, similarities or differences [43, 44].
Several steps were taken in the model development and data analysis to mitigate the potential impact of the unbalanced (in terms of gender) sample in the model results and subsequent analysis.
Fortunately, strategies are now available to fit growth curves for an entire sample in one model.
The sample in the model is a set of n subjects.
